Abstract
A method for plasma prekallikrein determination utilizing a chromo-genic tripeptide substrate is presented. The method has a good reproducibility and can easily be automized. Several parameters have been optimized. By using mixtures of deficient plasmas and pooled normal plasma or purified factors it was proved that prekallikrein was the factor determined and that more than 10% (of normal plasma concentration) of FXII and HMW kininogen were essential for the activation of prekallikrein in our method. Further experiments showed that the method was fairly selective and was not influenced by inhibitors present in normal plasma. The later finding was attributed to the high dilution of plasma made possible by using a potent activator and a sensitive substrate.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amundsen, E. and Svendsen, L.: A new method for plasma kallikrein utilizing a synthetic chromogenic substrate. In: New methods for the analysis of coagulation using chromogenic substrates. Ed. I. Witt, Walter de Gruyter. p. 211, 1977.
Aurell, L., Friberger, P., Karlsson, G. and Claeson, G.: A new sensitive and highly specific chromogenic peptide substrate for factor Xa. Thromb. Res. II: 595–609, 1977.
Bang, N.U. and Mattler, L.E.: Serine Protease Specificity for Peptide Chromogenic Substrates. Thromb. Haemost. 38: 776–92, 1977.
Burrowes, C.E., Habal, F.M. and Movat, H.Z.: The inhibition of human plasma kallikrein by antithrombia III. Thromb. Res. 7: 175–83, 1975.
Claeson, G., Friberger, P., Knds, M., and Eriksson, E.: Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase. Haemostasis 7: 76–78, 1978.
Donaldson, V.H., Glueck, H.I., Míller, M.A., Movat, H.Z. and Habal, F.: Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. J. Lab. Clin. Med. 87: 327–37, 1976.
Egberg, N. and Bergstrom, K.: Studies on assays for plasma prekallikrein and for the monitoring of cumarol therapy. Haemostasis 7: 85–91, 1978.
Friberger, P., Knos, M., Gustafsson, S., Aurell, L. and Claeson, G.: A new specific substrate for the determination of plasmin activity. In: Chromogenic Substrates. Ed. V.V. Kakkar. Churchill Livingstone. In press.
Gallimore, T.M., Fareid, E. and Stormorken, H.: The purification of a human plasma kallikrein with weak plasminogen activator activity. Thromb. Res. 12: 409–20, 1978.
Griffin, J.H.: Role of surface-dependent activation of Hageman factor (Blood coagulation Factor XII). Proc. Natl. Acad. Sci. 75: 1998–2002, 1978.
Kaplan, A.P., Meier, H.L. and Mandle, R.: The Hageman factor dependent pathway of coagulation, fibrinolysis and kinin generation. Seminars in Thrombosis and Haemostasis 3: 1–26, 1976.
Kluft, C.: Blood Fibrinolysis. Preactivators and activators in human plasma. Thesis. Dutch Efficiency Bureau-Pijnacker. p. 104, 1978.
Meier, H.L., Scott, C.F., Mandle, R., Webster, M.E., Pierce, J.V., Colman, R.W., and Kaplan, A.P.: Requirements for contact activation of human Hageman factor. Ann. N.Y. Acad. Sci. 283: 93–103, 1977.
Schreiber, A.D.: Plasma inhibitors of the Hageman factor dependent pathways. Seminars in Thrombosis and Haemostasis 3: 43–51, 1976.
Wiggins, R.C., Bouma, B.N., Cochrane, C.G. and Griffin, J.H.: Role of high-molecular-weight kininogen in surface binding and activation of coagulation Factor XI and prekallikrein. Proc. Natl. Acad. Sci. 74: 4634–40, 1977.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer Science+Business Media New York
About this chapter
Cite this chapter
Friberger, P., Eriksson, E., Gustavsson, S., Claeson, G. (1979). Determination of Prekallikrein in Plasma by Means of a Chromogenic Tripeptide Substrate for Plasma Kallikrein. In: Fujii, S., Moriya, H., Suzuki, T. (eds) Kinins—II. Advances in Experimental Medicine and Biology, vol 120. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-0926-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0926-1_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-0928-5
Online ISBN: 978-1-4757-0926-1
eBook Packages: Springer Book Archive